Lisoril is a medicine containing the active ingredient(s) lisinopril. On this page you will find out more about Lisoril, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: lisinopril
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Lisoril 2.5 mg uncoated tablet, 84
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Hypertension: For treatment of hypertension, lisinopril may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. Congestive heart failure: For treatment of heart failure, it is recommended that lisinopril be administered with a diuretic. Acute myocardial infarction: For treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmHg, lisinopril may be initiated within 24 hours of an acute myocardial infarction.
Table of characteristics
|Visual appearance||White to almost white, circular, biconvex, uncoated tablets with '2.5' embossing on one side and 'BL' embossing on the other side.|
|Dosage Form||Tablet, uncoated|
|Route of administration||Oral|
10: Prescription Only Medicine, or Prescription Animal Remedy
100: Prescription Only Medicine, or Prescription Animal Remedy
14: Prescription Only Medicine, or Prescription Animal Remedy
28 tablets: Prescription Only Medicine, or Prescription Animal Remedy
30 tablets: Prescription Only Medicine, or Prescription Animal Remedy
50: Prescription Only Medicine, or Prescription Animal Remedy
56 tablets: Prescription Only Medicine, or Prescription Animal Remedy
84 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.